Lipid nanoparticle-mediated Cd14 siRNA delivery ameliorates the acute inflammatory response to intracortical microelectrode implantation
Acta Biomaterialia · 2026-03 · 213 · 691-709
DOI: 10.1016/j.actbio.2026.01.055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-03. Verfasst von Francine Graham und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Advanced Platform Technology Center, Louis Stokes Clevelan…. Hauptthemen laut MEDLINE: Nanoparticles, Lipopolysaccharide Receptors, RNA, Small Interfering, Inflammation. Die Arbeit nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Intracortical microelectrodes (IMEs) are an integral component of brain computer interfaces (BCIs) designed to study and treat neurological disorders. Unfortunately, IMEs tend to fail prematurely due in part to the macrophage-mediated inflammation in response to implantation injury and the persistent foreign body reaction. Previous work has established that cluster of differentiation 14 (CD14) is implicated in the neuroinflammatory response to IME implants. CD14 is a conserved damage-associated coreceptor that facilitates immune activation in the presence of inflammatory damage-associated stimuli. We sought to mitigate the inflammatory response to IME implantation by suppressing CD14 expression on macrophages using a lipid nanoparticle (LNP) loaded with Cd14-specific siRNA. We tested the efficacy of the LNP-mediated gene delivery in cultured murine macrophages and in an in vivo mouse model with IME implants. Our in vitro findings indicated that the LNPs suppress inflammatory cytokine secretion. The in vivo studies showed efficient targeting of the LNPs to the desired cell populations with the majority of LNPs found in blood-circulating macrophages and infiltrating macrophages at the intracortical implant site. Our results show that the LNPs efficiently silence expression of the targeted Cd14 gene. Suppression of the CD14 protein led to reduced infiltration of immune cells to the brain parenchyma, as well as a significant decrease of the inflammatory response to implantation within the first 24 h after implantation, as determined by flow cytometry and transcriptomics. Together our results suggest that LNP-mediated gene therapy can specifically regulate one of the dominant drivers of the innate immune response to IME implantation. STATEMENT OF SIGNIFICANCE: Brain-computer interfaces rely on implanted electrodes to record and stimulate neural activity, but these devices often fail early because the body mounts an inflammatory immune response against them. Here, we focused on a central immune receptor, CD14, as a key driver of the inflammatory response to implants. Using lipid nanoparticles to deliver gene-silencing RNA, we were able to suppress CD14 expression in macrophages both in culture and in a mouse model with implanted electrodes. This targeted approach reduced immune cell infiltration and inflammation around implants. Our findings demonstrate that lipid nanoparticle-mediated gene therapy can selectively weaken the brain's innate immune response to implants, offering a promising strategy to improve the longevity and performance of neural interfaces.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Advanced Platform Technology Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA.
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
- Advanced Platform Technology Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA.
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Advanced Platform Technology Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA. Electroni…
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. Electronic address: s…
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- NIBIB NIH HHS
- National Institutes of Health National Cancer Institute
- National Institute of Neurological Disorders and Stroke
- National Institute of Biomedical Imaging and Bioengineering
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Graham, F., Hutchinson, D. W., Moon, T. J., Wang, J., Flores-Jimenez, H., Druschel, L., Ogunnaike, L., Gao, Y., Smith, T., DeTillio, S., Goelz, C., Bhalotia, A., Newman, L., Hess-Dunning, A., Capadona, J. R., & Karathanasis, E. (2026). Lipid nanoparticle-mediated Cd14 siRNA delivery ameliorates the acute inflammatory response to intracortical microelectrode implantation. Acta Biomaterialia, 213, 691-709. https://doi.org/10.1016/j.actbio.2026.01.055
Vancouver
Graham F, Hutchinson DW, Moon TJ, Wang J, Flores-Jimenez H, Druschel L, et al. Lipid nanoparticle-mediated Cd14 siRNA delivery ameliorates the acute inflammatory response to intracortical microelectrode implantation. Acta Biomaterialia. 2026;213:691-709. doi:10.1016/j.actbio.2026.01.055
BibTeX
@article{Graham2026,
author = {Graham, Francine and Hutchinson, Diarmuid W and Moon, Taylor J and Wang, Jaime and Flores-Jimenez, Heyda and Druschel, Lindsey and Ogunnaike, Laolu and Gao, Yue and Smith, Teagan and DeTillio, Samuel and Goelz, Coby and Bhalotia, Anubhuti and Newman, Lindsay and Hess-Dunning, Allison and Capadona, Jeffrey R and Karathanasis, Efstathios},
title = {Lipid nanoparticle-mediated Cd14 siRNA delivery ameliorates the acute inflammatory response to intracortical microelectrode implantation},
journal = {Acta Biomaterialia},
year = {2026},
volume = {213},
pages = {691--709},
doi = {10.1016/j.actbio.2026.01.055}
}
EUVIMED